 | This article needs additional citations for verification. (February 2017) |
 | |
| Company type | Public |
|---|---|
| NSE: AUROPHARMA BSE: 524804 | |
| Industry | Pharmaceuticals |
| Founded | 1986 |
| Founders | V. Ramprasad Reddy[1] K. Nityananda Reddy[1] |
| Headquarters | Hyderabad, Telangana, India |
| Products | |
| Revenue |  ₹29,002 crore (US$3.5 billion) (FY24)[3] |
| ₹5,843 crore (US$700 million) (FY24)[3] | |
| ₹3,173 crore (US$380 million) (FY24)[3] | |
| Total assets | ₹28,926 crore (US$3.5 billion) (2020)[4] |
| Total equity | ₹16,751 crore (US$2.0 billion) (2020)[4] |
Number of employees | 23,000[5] (2020) |
| Website | www |
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics.[6] The company markets these products in over 125 countries.[6] Its marketing partners include AstraZeneca[7] and Pfizer.[8]
- ^ a b "Aurobindo Overview".
- ^ "Aurobindo Pharma Limited Annual Report 2019-20" (PDF). Archived from the original (PDF) on 13 August 2020.
- ^ a b c "Earnings Presentation-Q4 FY 2023-24" (PDF). Aurobondo Pharma. Retrieved 29 May 2024.
- ^ a b "Aurobindo Pharma Ltd. Financial Statements". moneycontrol.com.
- ^ "Aurobindo Pharma Limited Annual Report 2016-17" (PDF). Archived from the original (PDF) on 21 January 2022.
- ^ a b "Aurobindo Pharma Ltd: Company Overview, History, Contacts | Brand India Pharma". www.brandindiapharma.in. Retrieved 15 October 2019.
- ^ "Aurobindo Pharma signs supply pact with AstraZeneca", The Economic Times, 6 September 2010
- ^ "Pfizer, Astra deals to drive Aurobindo Pharma's growth", The Economic Times, 5 November 2010